Postbiotic as Adjunct Treatment for Vaginal Candidiasis
ConditionVaginal Candidiasis
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexFemale
Age18-81
SponsorMin-Tze LIONG
About this trial
This project aims to study the efficacy of intravaginal administration of postbiotic at 1g/day as an adjunct treatment against vaginal candidiasis in women for 4-weeks compared to placebo.
Eligibility criteria
Qualifiers
Women who are sexually active
Confirmed with candidiasis as confirmed via clinical observations which include creamy whitish vaginal discharge and vulva-vaginal itchiness
Willing to commit throughout the experiment
Disqualifiers
Long term medication (6 months or more) for any illnesses
Pregnant
Menopaused
Uterus and/or cervix removed
Trial design
Treatments tested in this trial
- Postbiotic
- Placebo
Treatment groups
118 Participants
are divided into 2 treatment groupsSponsors and collaborators
Min-Tze LIONG
Lead sponsor
Universiti Sains Malaysia
Sponsor institution
AIMST University
Collaborator
Sumita Hospital
Collaborator
Source ClinicalTrials.gov